Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 5
Submit an article Journal homepage
219
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Radioimmunotherapy for orbital marginal zone lymphoma: a retrospective review

Andrea C. Loa Department of Radiation Oncology, British Columbia Cancer Vancouver, Vancouver, Canada;b Department of Surgery, University of British Columbia (UBC), Vancouver, Canada;c BC Cancer Centre for Lymphoid Cancer, Vancouver, CanadaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3253-1071
ORCID Icon,
Caroline L. Hollowayb Department of Surgery, University of British Columbia (UBC), Vancouver, Canada;c BC Cancer Centre for Lymphoid Cancer, Vancouver, Canada;d Department of Radiation Oncology, British Columbia Cancer Victoria, Victoria, CanadaORCID Iconhttps://orcid.org/0000-0003-3089-2006
ORCID Icon,
Kerry J. Savagec BC Cancer Centre for Lymphoid Cancer, Vancouver, Canada;e Department of Medical Oncology, British Columbia Cancer, Vancouver, Canada;f Department of Medicine, University of British Columbia (UBC), Vancouver, CanadaORCID Iconhttps://orcid.org/0000-0002-5835-9863
ORCID Icon,
Laurie H. Sehnc BC Cancer Centre for Lymphoid Cancer, Vancouver, Canada;e Department of Medical Oncology, British Columbia Cancer, Vancouver, Canada;f Department of Medicine, University of British Columbia (UBC), Vancouver, CanadaORCID Iconhttps://orcid.org/0000-0003-1860-9765
ORCID Icon,
Daniel F. Worsleyg Department of Nuclear Medicine, Vancouver General Hospital, Vancouver, Canada
,
Joseph M. Connorsc BC Cancer Centre for Lymphoid Cancer, Vancouver, Canada;e Department of Medical Oncology, British Columbia Cancer, Vancouver, Canada;f Department of Medicine, University of British Columbia (UBC), Vancouver, CanadaORCID Iconhttps://orcid.org/0000-0002-1361-7531
ORCID Icon &
Tom Picklesa Department of Radiation Oncology, British Columbia Cancer Vancouver, Vancouver, Canada;b Department of Surgery, University of British Columbia (UBC), Vancouver, Canada;c BC Cancer Centre for Lymphoid Cancer, Vancouver, CanadaORCID Iconhttps://orcid.org/0000-0002-2040-4630
ORCID Icon show all
Pages 1242-1245 | Received 08 Mar 2022, Accepted 22 Mar 2022, Published online: 05 May 2022
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Disclosure statement

KS: Consulting: Servier Inc. LS: Consultancy and has received honoraria: Incyte, Gilead, Kite, Janssen, Celgene, Acerta, Genentech Inc., AstraZeneca, Apobiologix, AbbVie, Amgen, Karyopharm, Lundbeck, Merck, MorphoSys, F. Hoffmann-La Roche Ltd, Seattle Genetics, Teva, Servier, Takeda, Chugai, TG therapeutics, and Verastem Oncology. Research funding: Genentech, Inc., F. Hoffmann-LaRoche Ltd, and Teva. TP: Honoraria: Servier Inc.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.